6d ago
TIGERMED - Overseas Regulatory Announcement - Self-Check Form for Equity Incentive Plans of GEM Listed Companies
HANGZHOU TIGERMED CONSULTING CO., LTD.
Hangzhou Tigermed Pharmaceutical Technology Co., Ltd.
(a joint stock limited company incorporated in the People's Republic of China)
(Stock code: 3347)
Overseas regulatory announcement
This announcement is made by Hangzhou Tigermed Pharmaceutical Technology Co., Ltd. (the "Company") in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The announcement published by the Company on the Shenzhen Stock Exchange website is set out below for reference only.
By order of the board of directors
Hangzhou Tigermed Pharmaceutical Technology Co., Ltd.
Chairman
Ye Xiaoping
Hong Kong, August 28, 2026
As at the date of this announcement, the executive directors are Dr. Ye Xiaoping, Ms. Cao Xiaochun and Mr. Wen Zengyu; the employee directors are Mr. Wu Hao; and the independent non-executive directors are Mr. Yuan Huagang, Ms. Liu Yuwen and Mr. Xiao Yaoxi.
Self-Check Form for Equity Incentive Plans of GEM Listed Companies Company Abbreviation: Tigermed Stock Code: 300347
Independent financial advisor: Shanghai Rongzheng Enterprise Consulting Services (Group) Co., Ltd.
Whether there is a note on the serial number of this matter (yes/no/not applicable) Compliance requirements for listed companies
Whether the financial accounting report for the most recent fiscal year has been registered will
1 Whether the accountant issues a negative opinion or an audit report in which he or she is unable to express an opinion
Internal control over financial reporting for the most recent fiscal year was approved by the registration committee
- Whether the accountant issues a negative opinion or an audit report in which he or she is unable to express an opinion.
In the past 36 months after listing, there has been any failure to comply with laws, regulations, and public regulations.
3 no
Articles of association and public commitment to profit distribution
4 Are there other circumstances that make it inappropriate to implement equity incentives? No 5 Have a performance appraisal system and methods been established? Yes
Whether to provide loans and any other forms of incentives to the incentive objects
6 No financial assistance
Incentive object compliance requirements
Does it include individually or collectively holding more than 5% of the shares of a listed company?
Shareholders or actual controllers and their spouses, parents and children
7 Yes/Yes and foreign employees, if so, does it mean that the above-mentioned persons have become militants?
Necessity and rationality of incentive objects
8 Whether independent directors are included? No
Whether it has been deemed inappropriate by a stock exchange within the last 12 months
9 No candidate
Recognized by the China Securities Regulatory Commission and its dispatched agencies within the last 12 months
10 Is it an unsuitable candidate?
The China Securities Regulatory Commission for serious violations of laws and regulations in the past 12 months
- Will the Commission and its dispatched agencies impose administrative penalties or take measures to ban market entry?
Shi
Whether the person is prohibited from serving as a company director or
12 no
Senior management situation
13 Are there any other circumstances that would make it inappropriate to be an incentive target? No
Whether the incentive list has been verified by the Remuneration and Appraisal Committee
14 yes
Incentive Program Compliance Requirements
All equity incentive plans of listed companies within the validity period are involved
- Whether the cumulative total number of underlying stocks exceeds 20% of the company’s total share capital? No.
Whether the cumulative number of shares granted to a single incentive object exceeds the company’s share capital
16 No 1% of total amount
Whether the reserved equity ratio of incentive objects does not exceed the equity incentive ratio of this equity incentive
17 Not applicable 20% of the number of rights to be granted under the incentive plan
The incentive targets are directors, senior managers, individual or aggregate shareholders
Shareholders or actual controllers holding more than 5% of the shares and their spouses, parents,
18 For children and foreign employees, has the draft equity incentive plan been
List their name, position, and number of awards
The validity period of the equity incentive plan is calculated from the date of authorization.
19 is more than 10 years
Is the draft equity incentive plan the responsibility of the remuneration and appraisal committee?
20 is responsible for formulating
Equity Incentive Plan Disclosure Completeness Requirements
21 Whether the matters stipulated in the equity incentive plan are complete is: (1) Compare the provisions of the "Equity Incentive Management Measures", item by item
Explain whether listed companies are not allowed to implement equity incentives and
Incentive objects are not allowed to participate in equity incentives; explain whether the implementation of the equity incentive plan will cause the equity distribution of listed companies to be inconsistent.
Meet listing conditions
(2) The purpose of the equity incentive plan and the basis for determining the incentive objects
basis and scope
(3) The number of equity interests to be granted by the equity incentive plan and its share of the listed
Proportion of the company’s total share capital; if implemented in stages, each proposed grant is
The number of equity interests granted and the proportion to the total share capital of the listed company;
If reserved rights are reserved, the number of rights to be reserved and the proportion of the total rights in the equity incentive plan; whether the total number of subject stocks involved in all equity incentive plans within the validity period exceeds 20% of the company's total share capital and an explanation of the calculation method
(4) Except for the reserved part, if the incentive objects are directors and senior managers of the company, their names, positions, the number of rights and interests that can be granted to each, and the proportion of the total rights and interests to be granted in the equity incentive plan shall be disclosed; other incentive objects (each or according to appropriate classification)
It is the number of rights that can be granted and its proportion to the total number of rights to be granted by the equity incentive plan; and an explanation of whether the cumulative number of company shares granted to a single incentive object through all equity incentive plans within the validity period exceeds 1% of the company's total share capital.
(5) Validity period, authorization date or authorization of the equity incentive plan
How to determine the date, vesting date, lock-up period arrangement, etc.
(6) The grant price of restricted stocks, the exercise price of stock options and their determination methods. The "Equity Incentive Management Measures" were not adopted
If the party specified in Articles 23 and 29 determines the grant price or exercise price, it shall explain the basis and method of pricing, and independent directors and independent financial advisors shall verify whether the pricing harms the interests of the listed company and small and medium-sized shareholders, express their opinions and disclose
(7) Conditions for incentive objects to be granted and exercise their rights. If it is planned to grant the rights and interests in installments, the conditions for each grant of the rights to the incentive objects shall be disclosed; if the rights and interests are to be exercised in installments, the conditions for each exercise of the rights and interests by the incentive objects shall be disclosed; when the conditions for granting the rights and exercising the rights and interests are not met, the relevant rights and interests shall not be deferred to the next period; if the incentive objects include directors and senior managers, the performance of the incentive objects for exercising the rights and interests shall be disclosed. Effectiveness assessment indicators; when disclosing the performance assessment indicators for incentive objects to exercise their rights and interests, the scientific nature and rationality of the set indicators should be fully disclosed; if the company implements multiple equity incentive plans at the same time, if the company's performance indicators in the later incentive plan are lower than those in the previous incentive plan, the reasons and rationality should be fully explained (8) The company's procedures for granting rights and interests and for incentive objects to exercise their rights;
Among them, it should be clear that listed companies are not allowed to grant restricted stocks to
and the period during which incentive objects are not allowed to exercise their rights and interests.
(9) The number of interests and exercise price involved in the equity incentive plan
Adjustment methods and procedures (such as adjustment methods when implementing profit distribution, share allotment, etc. plans)
(10) Accounting treatment method for equity incentives, restricted stocks or
Determination method of fair value of stock options, important parameters of valuation model
It is the value of the number and its rationality. Expenses should be accrued for the implementation of equity incentives.
and its impact on the operating performance of listed companies.
(11) Changes and terminations of equity incentive plans are
(12) The company undergoes changes in control, mergers, divisions, and incentives
How to implement the equity incentive plan when the target changes his position, leaves his job, dies, etc.
(13) The respective rights and obligations of the company and the incentive objects, and relevant disputes
Dispute or dispute settlement mechanism
(14) Information disclosure related to equity incentive plans of listed companies
There are no false records, misleading statements or major omissions in the documents
commitment; there are false records in relevant disclosure documents of incentive objects,
Misleading statements or major omissions leading to non-compliance with the rights granted
It is a commitment that all benefits will be returned to the company if the rights are exercised.
Triggering of equity repurchase and cancellation and earnings recovery procedures for listed companies
Standards and timing, calculation principles and operations of repurchase prices and profits
procedures, completion deadlines, etc.
Whether performance appraisal indicators meet relevant requirements
Whether to include company performance indicators and individual performance indicators of incentive targets?
22 is the standard
Are the indicators objective, open, clear and transparent, and consistent with the company’s actual conditions?
23 is the situation, whether it is conducive to promoting the company's competitiveness
Based on the relevant indicators of comparable companies in the same industry as a comparison basis, select
24 Not applicable
Whether the number of comparison companies is no less than 3
25 Does it explain the scientificity and rationality of setting indicators?
Compliance requirements for lock-up period, vesting period, and exercise period
26 The authorization registration date and first release of restricted stocks (Class I) are not applicable.
Whether the interval between days is less than 1 year
27 Whether the time limit for lifting the sales restriction in each period is not less than 12 months Not applicable
Whether the proportion of sales restrictions lifted in each period does not exceed the number of incentive objects awarded
28 Not applicable 50% of total restricted stock
The period between the grant date and the first vesting date of restricted stocks (Class II)
29 no
Whether the interval is less than 1 year
30 Whether the time limit of each vesting period is not less than 12 months?
Whether the vesting ratio of each period does not exceed the incentive object’s grant limit
31 is 50% of the total number of shares
The interval between the grant date of a stock option and the first exercisable date
32 N/A Whether it is less than 1 year
Whether the starting date of the next exercise period for stock options is no earlier than the previous one
33 Not applicable
Expiration date of exercise period
34 Whether the exercise period of each stock option is not less than 12 months Not applicable
Whether the proportion of stock options exercisable in each period does not exceed
35 Not applicable
50% of the total stock options granted to the over-incentive recipients
Compliance requirements for professional opinions of remuneration and appraisal committees and intermediaries
Whether the Remuneration and Appraisal Committee discusses whether the equity incentive plan has any
36 Express opinions on whether it is conducive to the sustainable development of the listed company and whether there is obvious harm to the interests of the listed company and all shareholders.
Whether the listed company hires a law firm to issue a legal opinion?
37 and issue professional opinions in accordance with the provisions of the "Equity Incentive Management Measures"
(1) Whether the listed company complies with the "Equity Incentive Management Measures"
It is the stipulated condition for implementing equity incentives.
(2) Whether the content of the equity incentive plan complies with the "Equity Incentive Plan"
It is the provisions of the Management Measures
(3) Procedures for the formulation, review, and public announcement of equity incentive plans
Whether it complies with the provisions of the "Equity Incentive Management Measures"
(4) Whether the determination of equity incentive objects complies with the "Equity Incentive
It is the provisions of the Management Measures and relevant laws and regulations
(5) Whether the listed company has complied with the relevant requirements of the China Securities Regulatory Commission
Yes
Request to fulfill information disclosure obligations
(6) Whether the listed company provides financial assistance to the incentive recipients? (7) Whether the equity incentive plan obviously harms the listed company
and the interests of all shareholders and violations of relevant laws and administrative regulations.
(8) Directors who are intended to be incentive targets or are related to them
Whether the related directors have recused themselves in accordance with the provisions of the "Equity Incentive Management Measures"
(9) Other matters that should be explained are not applicable
If a listed company hires an independent financial adviser, the independent financial adviser’s report
38 Whether the professional opinions expressed in the report are complete and comply with the requirements of the "Equity Incentive Management Measures"
Review program compliance requirements
When the board of directors votes on the draft equity incentive plan, whether the associated directors
39 is to avoid voting
When the shareholders' meeting considers the draft equity incentive plan, the related shareholders are
40 Not applicable
Do you intend to avoid voting?
41 Are there any financial innovation matters? No
The company guarantees that the information filled in is true, accurate, complete and legal, and assumes all legal responsibilities arising from errors in the information filled in.
Hangzhou Tigermed Pharmaceutical Technology Co., Ltd.
August 29, 2026